OPRM1 and cancer: The mean intraoperative sufentanil consumption was significantly higher in patients with high levels of MOR in their tumours (65.34 ± 4.80μg) than in those with cancers expression low levels of the receptor (45.60 ± 4.60μg) (P<0.001, Figure 1A).